We provide one-stop, high-caliber services to meet the varied needs of clients of different sectors and in different development stages by virtue of our integrated service platform. We have a seasoned and influential bench consisting of dozens of partners and associates who have served years in the pharmaceuticals and life sciences sector. With solid expertise and abundant experience, as well as a deep insight into the patterns and trends of this sector, our lawyers actively participate in research and formulation of public policies and innovation of transaction types and models.
As a market leader in the legal services related to pharmaceuticals, healthcare, and life sciences, we never deviate from our continued efforts to increase the scope and sophistication of our services and enhance the innovation of our service models. Our work spans sub-sectors of new drugs, bioproducts, reagents, pharmaceuticals, CRO, CDMO, medical devices, gene-editing, gene sequencing, and genetic diagnosis, human body data collection and monitoring, bio-equivalence; distribution of drugs; health foods; cosmetics; biomedical funds, and incubation platforms. With a wide range of capabilities covering the entire industry chain, we provide services encompassing incorporation, financing, incentive plan, in-license, out-license and protection of intellectual property, M&A, IPO, compliant operation, anti-corruption, antitrust, dispute resolution, and other matters. Keeping abreast with the latest policies and development models of the industry, we are both down-to-earth and forward-looking in our services, which helps us maintain a widely respected profile in the market.